AI assistant
Editas Medicine, Inc. — Director's Dealing 2016
Feb 3, 2016
33260_dirs_2016-02-02_c0a5481b-ca3e-445b-9a72-6a4a04fbd566.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Editas Medicine, Inc. (EDIT)
CIK: 0001650664
Period of Report: 2016-02-02
Reporting Person: Joung J. Keith (10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 480769 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $6.48 | 2025-09-13 | Common Stock (96153) | Direct |
Footnotes
F1: These shares are restricted stock owned by MMK Tech LLC ("MMK") and issued pursuant to a restricted stock agreement between the Issuer and MMK. Twenty-five percent of the shares vested on November 21, 2013, and the remainder are scheduled to vest in equal monthly installments from August 1, 2013 until August 1, 2017.
F2: The shares are held directly by MMK. The sole managing member of MMK is the Jae Keith Joung 2007 Revocable Trust (the "Trust"). J. Keith Joung is a trustee of the Trust and therefore may be deemed to beneficially own the shares held by MMK.
F3: This option was granted on September 14, 2015 and is scheduled to vest over four years with the shares scheduled to vest in equal quarterly installments beginning on December 10, 2015.